ANAB logo

AnaptysBio, Inc. (ANAB)

Profile

Full Name

AnaptysBio, Inc.

Ticker

NASDAQ: ANAB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 26, 2017

Indexes

Not included

Website

https://www.anaptysbio.com

Employees

136

Key Details

Price

$20.25(-0.56%)

Market cap

$566.31M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$91.28M(+432.03% YoY)

Annual EPS

-$5.12(+15.79% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $20.25
    ANAB price is $20.25

    30-Day Relative Volume

    0.59
    ANAB 30-day relative volume is 0.59

    Price Performance

    Price Today change

    -0.56%
    ANAB price is down -0.56% today

    Price YTD change

    +52.91%
    ANAB price is up +52.91% since January 1st

    Price 1-year change

    -45.71%
    ANAB price is down -45.71% year-on-year

    Price 3-year change

    -12.05%
    ANAB price is down -12.05% over the past 3 years

    Price Range

    Price All-time high

    $134.00
    ANAB price is currently -84.89% below its historical high of $134.00

    Price 3-year low

    $12.21
    ANAB price is currently +65.81% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $566.31M
    ANAB market capitalization is $566.31 million

    Market cap 3-year change

    -12.88%
    ANAB market capitalization is down -12.88% over the past 3 years

    Market cap All-time high

    $3.06B
    ANAB market capitalization is currently -81.50% below its historical high of $3.06 billion

    Market cap sector rank

    66.64%
    ANAB market capitalization is higher than 66.64% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -7.37%
    ANAB shares outstanding is down -7.37% year-on-year

    Shares Outstanding 3-Year Change

    -0.94%
    ANAB shares outstanding is down -0.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.76
    ANAB beta is 0.76

    200-day SMA

    $19.92
    ANAB price is currently +1.65% above its 200-day simple moving average

    50-day SMA

    $23.69
    ANAB price is currently -14.55% below its 50-day simple moving average

    RSI

    35.38
    ANAB 14-day relative strength index is 35.38

    Volume

    0.59
    ANAB 30-day relative volume is 0.59

    ATR

    $1.16
    ANAB average true range is $1.16

    10-day Historical Volatility

    42.29%
    ANAB 10-day historical volatility is 42.29%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $91.28M
    ANAB annual revenue is $91.28 million

    Revenue Analysts estimate

    $111.15M
    ANAB annual revenue is currently -17.88% lower than the consensus analysts' forecast

    Revenue 1-year change

    +432.03%
    ANAB annual revenue is up +432.03% year-on-year

    Revenue Sector rank

    68.01%
    ANAB annual revenue is higher than 68.01% of companies in Healthcare sector

    EPS

    EPS

    -$5.12
    ANAB annual earnings per share is -$5.12

    EPS Analysts estimate

    -$4.80
    ANAB annual earnings per share is currently +6.69% higher than the consensus analysts' forecast

    EPS 1-year change

    +15.79%
    ANAB annual earnings per share is up +15.79% year-on-year

    EPS Sector rank

    19.35%
    ANAB annual earnings per share is higher than 19.35% of companies in Healthcare sector

    Profit

    Gross profit

    $88.88M
    ANAB annual gross profit is $88.88 million

    Gross margin

    97.37%
    ANAB annual gross profit margin is 97.37%

    Operating profit

    -$114.95M
    ANAB annual operating income is -$114.95 million

    Operating margin

    -125.93%
    ANAB annual operating profit margin is -125.93%

    Net income

    -$145.23M
    ANAB annual net profit is -$145.23 million

    Net margin

    -159.11%
    ANAB annual net profit margin is -159.11%

    Expenses

    Total expenses

    $206.23M
    ANAB annual total expenses is $206.23 million

    Operating expenses

    $206.23M
    ANAB annual total operating expenses is $206.23 million

    Cost of goods sold

    $2.40M
    ANAB annual cost of goods sold is $2.40 million

    Selling, general & administrative expenses

    $42.39M
    ANAB annual SGA is $42.39 million

    Depreciation and amortization

    $2.40M
    ANAB annual depreciation & amortization is $2.40 million

    Interest expense

    $50.09M
    ANAB annual interest expense is $50.09 million

    Income tax

    $3000.00
    ANAB annual income tax is $3000.00

    EBIT & EBITDA

    EBIT

    -$95.14M
    ANAB annual earnings before interest & taxes is -$95.14 million

    EBITDA

    -$92.74M
    ANAB annual EBITDA is -$92.74 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $483.83M
    ANAB annual total assets is $483.83 million

    Non current assets

    $51.96M
    ANAB annual long term assets is $51.96 million

    Current assets

    $431.88M
    ANAB annual total current assets is $431.88 million

    Cash and cash equivalents

    $123.08M
    ANAB annual cash & cash equivalents is $123.08 million

    Accounts receivable

    $40.77M
    ANAB annual accounts receivable is $40.77 million

    Inventory

    $0.00
    ANAB annual inventory is $0.00

    Liabilities

    Total liabilities

    $412.97M
    ANAB annual total liabilities is $412.97 million

    Long term liabilities

    $367.54M
    ANAB annual total long term liabilities is $367.54 million

    Current liabilities

    $45.43M
    ANAB annual total current liabilities is $45.43 million

    Accounts payable

    $4.00M
    ANAB annual accounts payable is $4.00 million

    Debt

    Total debt

    $16.04M
    ANAB annual total debt is $16.04 million

    Total debt 1-year change

    -9.98%
    ANAB annual total debt is down -9.98% year-on-year

    Long term debt

    $14.11M
    ANAB annual long term debt is $14.11 million

    Short term debt

    $1.93M
    ANAB annual short term debt is $1.93 million

    Equity & Capital

    Shareholders equity

    $70.87M
    ANAB annual stockholders equity is $70.87 million

    Book value

    $70.87M
    ANAB annual book value is $70.87 million

    Retained earnings

    -$759.33M
    ANAB annual retained earnings is -$759.33 million

    Working capital

    $386.45M
    ANAB annual working capital is $386.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$135.34M
    ANAB annual cash flow from operations is -$135.34 million

    Cash from operations 1-year change

    -12.03%
    ANAB annual cash flow from operations is down -12.03% year-on-year

    Cash from investing

    $95.40M
    ANAB annual cash flow from investing activities is $95.40 million

    Cash from investing 1-year change

    -34.1%
    ANAB annual cash flow from investing activities is down -34.1% year-on-year

    Cash from financing

    $127.05M
    ANAB annual cash flow from financing activities is $127.05 million

    Cash from financing 1-year change

    +314.27%
    ANAB annual cash flow from financing activities is up +314.27% year-on-year

    CAPEX

    CAPEX

    $358.00K
    ANAB annual capital expenditures is $358.00 thousand

    CAPEX 1-year change

    -55.64%
    ANAB annual capital expenditures is down -55.64% year-on-year

    Free Cash Flow

    Free cash flow

    -$135.69M
    ANAB annual free cash flow is -$135.69 million

    Free cash flow 1-year change

    -11.58%
    ANAB annual free cash flow is down -11.58% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    97.37%
    ANAB annual gross profit margin is 97.37%

    Operating margin

    -125.93%
    ANAB annual operating profit margin is -125.93%

    Net margin

    -159.11%
    ANAB annual net profit margin is -159.11%

    ROA & ROE

    ROA

    -31.02%
    ANAB annual return on assets is -31.02%

    ROE

    -182.71%
    ANAB annual return on equity is -182.71%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ANAB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ANAB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -12.66
    ANAB price to book ratio is -12.66

    PB ratio Sector rank

    3.75%
    ANAB price to book ratio is higher than 3.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.60
    ANAB price to sales ratio is 4.60

    PS ratio Sector rank

    56.6%
    ANAB price to sales ratio is higher than 56.6% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $647.06M
    ANAB enterprise value is $647.06 million

    Enterprise value Sector rank

    69.18%
    ANAB enterprise value is higher than 69.18% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.73
    ANAB EV/EBITDA is -7.73

    EV/EBITDA Sector rank

    16.21%
    ANAB EV/EBITDA is higher than 16.21% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    9.51
    ANAB annual current ratio is 9.51

    Quick ratio

    9.51
    ANAB annual quick ratio is 9.51

    Leverage

    Debt to equity

    0.00
    ANAB annual debt to equity ratio is 0.00

    Interest coverage ratio

    -1.90
    ANAB annual interest coverage ratio is -1.90

    Risk & Stability

    Piotroski F-Score

    4
    ANAB piotroski f-score is 4

    Altman Z-Score

    -0.88
    ANAB altman z-score is -0.88

    Analyst ratings

    Recent major analysts updates

    Aug 12, 25 UBS
    Neutral
    Aug 7, 25 Wedbush
    Outperform
    Jul 24, 25 JP Morgan
    Overweight
    Jun 4, 25 HC Wainwright & Co.
    Buy
    May 28, 25 Guggenheim
    Buy
    May 6, 25 Guggenheim
    Buy
    May 1, 25 Wedbush
    Outperform
    Mar 5, 25 JP Morgan
    Overweight
    Mar 4, 25 HC Wainwright & Co.
    Neutral
    Feb 13, 25 Wells Fargo
    Overweight

    Institutional Ownership

    Screeners with ANAB included

    US stocks
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Companies with buyback
    • What is the ticker symbol for AnaptysBio, Inc.?
    • Does AnaptysBio, Inc. pay dividends?
    • What sector is AnaptysBio, Inc. in?
    • What industry is AnaptysBio, Inc. in?
    • What country is AnaptysBio, Inc. based in?
    • When did AnaptysBio, Inc. go public?
    • Is AnaptysBio, Inc. in the S&P 500?
    • Is AnaptysBio, Inc. in the NASDAQ 100?
    • Is AnaptysBio, Inc. in the Dow Jones?
    • When was AnaptysBio, Inc.'s last earnings report?
    • When does AnaptysBio, Inc. report earnings?

    What is the ticker symbol for AnaptysBio, Inc.?

    The ticker symbol for AnaptysBio, Inc. is NASDAQ:ANAB

    Does AnaptysBio, Inc. pay dividends?

    No, AnaptysBio, Inc. does not pay dividends

    What sector is AnaptysBio, Inc. in?

    AnaptysBio, Inc. is in the Healthcare sector

    What industry is AnaptysBio, Inc. in?

    AnaptysBio, Inc. is in the Biotechnology industry

    What country is AnaptysBio, Inc. based in?

    AnaptysBio, Inc. is headquartered in United States

    When did AnaptysBio, Inc. go public?

    AnaptysBio, Inc.'s initial public offering (IPO) was on January 26, 2017

    Is AnaptysBio, Inc. in the S&P 500?

    No, AnaptysBio, Inc. is not included in the S&P 500 index

    Is AnaptysBio, Inc. in the NASDAQ 100?

    No, AnaptysBio, Inc. is not included in the NASDAQ 100 index

    Is AnaptysBio, Inc. in the Dow Jones?

    No, AnaptysBio, Inc. is not included in the Dow Jones index

    When was AnaptysBio, Inc.'s last earnings report?

    AnaptysBio, Inc.'s most recent earnings report was on August 7, 2025

    When does AnaptysBio, Inc. report earnings?

    The next expected earnings date for AnaptysBio, Inc. is November 5, 2025
    On this page